touchPODCAST

touchTALKS for touchCARDIO A thrombosis and haemostasis expert shares insights into reversal strategies for patients with direct oral anticoagulant-associated intracranial haemorrhage (DOAC-ICH), including benefits and risks of DOAC use, evidence for DOAC reversal agents and guideline-directed management of the condition.  The expert Prof. Dr. med. Jan Beyer-Westendorf, University Hospital Carl Gu...

touchFOCUS for touchONCOLOGY   Listen to Dr Dana Chase discuss the role of HER2 as a pan-tumour biomarker and the implications for treatment across various cancer types. The expert Dr Dana Chase - UCLA Health, Los Angeles, CA, USA   This touchPODCAST is for HCPs only.   This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Heal...

touchEXPERT OPINIONS for touchENDOCRINOLOGY Listen to three leading Fabry disease experts discuss early diagnosis, organ monitoring, long-term individualized care and future directions. The experts Prof. Aleš Linhart, Charles University and General University Hospital, Prague, Czech Republic Dr Eric Wallace, University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA Prof. William...

touchEXPERT OPINIONS for touchCARDIO Listen to three leading Fabry disease experts discuss early diagnosis, organ monitoring, long-term individualized care and future directions. The experts Prof. Aleš Linhart, Charles University and General University Hospital, Prague, Czech Republic Dr Eric Wallace, University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA Prof. William Wilcox,...

touchEXPERT OPINIONS for touchNEUROLOGY Listen to three leading Fabry disease experts discuss early diagnosis, organ monitoring, long-term individualized care and future directions. The experts Prof. Aleš Linhart, Charles University and General University Hospital, Prague, Czech Republic Dr Eric Wallace, University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA Prof. William Wilc...

touchEXPERT OPINIONS for touchINFECTIOUS DISEASES Listen to leading experts describe the HIV life cycle, the rationale for multidrug antiretroviral therapy (ART) regimens, mechanisms of ART resistance and how to manage it in people living with HIV. The experts Prof. Anne-Mieke Vandamme - Katholieke Universiteit Leuven, Belgium Prof. José Arribas - La Paz Hospital, Madrid, Spain Prof. Antonella Cas...

touchIN CONVERSATION for touchONCOLOGY Listen to Ms Nikolina Dodlek, an oncology nurse from Croatia, in conversation with Professor Sherko Kümmel, a leading medical oncologist from Germany. They respond to questions submitted by the HCP audience and provide their expert insights on the use of HER2-directed antibody–drug conjugates (ADCs) in the treatment of patients with breast cancer. This touchP...

touchPANEL DISCUSSION for touchONCOLOGY  Listen to a panel of leading experts discuss the latest evidence and clinical implications of recently approved treatments for relapsed/refractory follicular lymphoma (R/R FL), the importance of shared decision-making in treatment selection in the era of BsAb and CAR T-cell therapies, and the key considerations for treatment sequencing.  The experts Dr Matt...

touchPANEL DISCUSSION for touchHAEMATOLOGY Listen to a panel of leading experts discuss the latest evidence and clinical implications of recently approved treatments for relapsed/refractory follicular lymphoma (R/R FL), the importance of shared decision-making in treatment selection in the era of BsAb and CAR T-cell therapies, and the key considerations for treatment sequencing.  The experts Dr Ma...

touchIN CONVERSATION for touchRESPIRATORY Listen to a medical oncologist and a pathologist as they discuss HER2 alterations in non-small cell lung cancer (NSCLC), including the different types of HER2 alterations, key considerations for HER2 testing and the latest data for HER2-targeting treatments.  The experts Prof. Enriqueta Felip - Medical Oncologist, Vall d'Hebron University Hospital, Barcelo...

touchIN CONVERSATION for touchONCOLOGY Listen to a medical oncologist and a pathologist as they discuss HER2 alterations in non-small cell lung cancer (NSCLC), including the different types of HER2 alterations, key considerations for HER2 testing and the latest data for HER2-targeting treatments.  The experts Prof. Enriqueta Felip - Medical Oncologist, Vall d'Hebron University Hospital, Barcelona,...

touchIN CONVERSATION for touchNEUROLOGY - Early diagnosis and treatment of NMOSD: Practical insights Listen to a neurologist and a neuro-ophthalmologist, both renowned experts in neuromyelitis optica spectrum disorder (NMOSD), answer questions from the ophthalmology and neurology communities on the management of NMOSD. They discuss presenting symptoms, differential diagnoses, management of acute a...

touchIN CONVERSATION for touchOPTHAMOLOGY Listen to a neurologist and a neuro-ophthalmologist, both renowned experts in neuromyelitis optica spectrum disorder (NMOSD), answer questions from the ophthalmology and neurology communities on the management of NMOSD. They discuss presenting symptoms, differential diagnoses, management of acute attacks and long-term treatment. The experts: Prof. John Che...

touchMDT for touchHAEMATOLOGY Listen to an HLH specialist and a paediatric intensivist discuss the clinical features of HLH in patients and when it is important to have a high index of suspicion of HLH. The multidisciplinary team HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA Paediatric intensivist: Dr Kate Kernan, Pittsburgh, PA, USA This touchPODCAST is for healthcare professionals in...

touchMDT for touchHAEMATOLOGY Listen to an HLH specialist and a pathologist discuss the role of the pathologist in the diagnostic workup of patients suspected of having HLH, including the insights available from bone marrow biopsy in identifying triggers for HLH. The multidisciplinary team HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA Pathologist: Dr Eric Gars, Gainesville, FL, USA Thi...

touchMDT for touchHAEMATOLOGY Listen to an HLH specialist, paediatric intensivist and critical care pharmacist discuss the importance of an individualized approach to the treatment of HLH, particularly when considering the age of the patient.  The multidisciplinary team HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA Paediatric intensivist: Dr Kate Kernan, Pittsburgh, PA, USA Critical ca...

touchMDT for touchHAEMATOLOGY Listen to an HLH specialist and a paediatric intensivist discuss the standard of care for patients with primary HLH and highlight the introduction of novel agents for second-line therapy for patients who do not respond in the first line. The multidisciplinary team HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA Paediatric intensivist: Dr Kate Kernan, Pittsbu...

touchMDT for touchIMMUNOLOGY Listen to an HLH specialist and a paediatric intensivist discuss the clinical features of HLH in patients and when it is important to have a high index of suspicion of HLH. The multidisciplinary team HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA Paediatric intensivist: Dr Kate Kernan, Pittsburgh, PA, USA This touchPODCAST is for healthcare professionals in...

touchMDT for touchIMMUNOLOGY Listen to an HLH specialist and a pathologist discuss the role of the pathologist in the diagnostic workup of patients suspected of having HLH, including the insights available from bone marrow biopsy in identifying triggers for HLH. The multidisciplinary team HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA Pathologist: Dr Eric Gars, Gainesville, FL, USA This...

touchMDT for touchIMMUNOLOGY Listen to an HLH specialist, paediatric intensivist and critical care pharmacist discuss the importance of an individualized approach to the treatment of HLH, particularly when considering the age of the patient.  The multidisciplinary team HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA Paediatric intensivist: Dr Kate Kernan, Pittsburgh, PA, USA Critical car...

touchMDT for touchIMMUNOLOGY Listen to an HLH specialist and a paediatric intensivist discuss the standard of care for patients with primary HLH and highlight the introduction of novel agents for second-line therapy for patients who do not respond in the first line. The multidisciplinary team HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA Paediatric intensivist: Dr Kate Kernan, Pittsbur...

touchIN CONVERSATION for touchNEUROLOGY Listen to Dr Carolyn Clevenger, a gerontological nurse practitioner, in conversation with family care partner Ms Kathleen Rhyne. They respond to questions submitted by the HCP audience, providing valuable insights on agitation in Alzheimer’s dementia with a focus on prevalence, behavioural symptoms and the importance of early recognition and diagnosis. This...

touchPANEL DISCUSSION for touchONCOLOGY Listen to a panel of leading experts—a renowned allergist, dermatologist, and haemato-oncologist—discuss the diagnosis and management of systemic mastocytosis, including current and emerging treatment options and multidisciplinary approaches to optimize patient care. The experts Prof. Dr Vito Sabato, University of Antwerp, Antwerp, Belgium Dr Sigurd Broesby-...

touchPANEL DISCUSSION for touchHAEMATOLOGY  Listen to a panel of leading experts—a renowned allergist, dermatologist, and haemato-oncologist—discuss the diagnosis and management of systemic mastocytosis, including current and emerging treatment options and multidisciplinary approaches to optimize patient care. The experts Prof. Dr Vito Sabato, University of Antwerp, Antwerp, Belgium Dr Sigurd Broe...

touchPANEL DISCUSSION for touchDERMATOLOGY  Listen to a panel of leading experts—a renowned allergist, dermatologist, and haemato-oncologist—discuss the diagnosis and management of systemic mastocytosis, including current and emerging treatment options and multidisciplinary approaches to optimize patient care. The experts Prof. Dr Vito Sabato, University of Antwerp, Antwerp, Belgium Dr Sigurd Broe...